Investigating the Complications and Causes of Failure of the AngioVac System: A Post-Marketing Surveillance From the MAUDE Database

Background Aspiration thrombectomy devices, such as the AngioVac, allow the removal of thrombus, especially in patients with contraindications to anticoagulation use. The AngioVac was approved by the U.S. Food and Drug Administration to remove fresh, soft thrombi or emboli during extracorporeal bypa...

Descripción completa

Detalles Bibliográficos
Autores principales: Dandu, Chaitu, Alamzaib, Sardar Muhammad, Patel, Dhruvil, Naughton3, Ryan, Polina, Aws, Najam, Maria, Alhusain, Rashid, Patel, Neel, Sattar, Yasar, Alraies, M. Chadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiac/Thoracic/Vascular Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505590/
https://www.ncbi.nlm.nih.gov/pubmed/37727161
http://dx.doi.org/10.7759/cureus.43720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505590/
https://www.ncbi.nlm.nih.gov/pubmed/37727161
http://dx.doi.org/10.7759/cureus.43720

Ejemplares similares